Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Eur J Emerg Med. 2021 Jan 1;28(1):64–69. doi: 10.1097/MEJ.0000000000000753

Figure 2.

Figure 2

A) Performance of HEART score in Predicting 30-Day MACE in patients with Cancer in Remission and their counterparts; B) Rate of 30-Day MACE in low risk vs intermediate to high risk HEART classes in Study Groups